Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer. Sonke GS, van Ommen-Nijhof A, Wortelboer N, van der Noort V, et al. Nature 2024 Nov 27. doi: 10.1038/s41586-024-08035.

Read + Share

Amedeo Smart

Independent Medical Education

Sonke GS, van Ommen-Nijhof A, Wortelboer N, van der Noort V, et al. Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer. Nature 2024 Nov 27. doi: 10.1038/s41586-024-08035.
PMID: 39604725